Product Information
VALGANCICLOVIR HCL 50 MG/ML is a generic product labeled by Major Pharmaceuticals, priced at $1.3267 per ML under NDC 00904741904. Its NADAC has been published 84 times since Oct 23, 2024.
FDA first approved this application on Feb 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/mL
Manufacturer
Major PharmaceuticalsNDC
00904741904
Classification
Generic
Dosage Form
FOR SOLUTION
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
VALGANCICLOVIR HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210169FDA Approved
2/17/2022
TE Code
AB
On Market Since
2/17/2022
Pharmacological Classes
Price Statistics
The NADAC for VALGANCICLOVIR HCL 50 MG/ML has been published 84 times since Oct 23, 2024, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3267 per ML |
|---|---|
| All-time high | $2.3657 (Jun 11, 2025) |
| All-time low | $1.1648 (Oct 22, 2025) |
| 52-week high | $1.4406 |
| 52-week low | $1.1648 |
| Median price | $1.8390 |
| Average price | $1.7214 |
| Largest weekly change | -19.4% (Aug 20, 2025) |
| Weeks tracked | 84 |
| Tracking since | Oct 23, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
-7.9%
1Y
+5.8%
3Y
N/A
5Y
N/A
All
-32.4%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
valganciclovir hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALGANCICLOVIR HCL 50 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR HCL 50 MG/ML, manufactured by Major Pharmaceuticals, is $1.3267 per ML (NDC 00904741904), effective May 27, 2026.
How has the price of VALGANCICLOVIR HCL 50 MG/ML changed over time?
Over the history we have for it, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has declined 32.4%. It has been tracked across 84 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR HCL 50 MG/ML?
Since Oct 23, 2024, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has ranged from a low of $1.1648 (Oct 22, 2025) to a high of $2.3657 (Jun 11, 2025), with a median of $1.8390 per ML.
Are there cheaper alternatives to VALGANCICLOVIR HCL 50 MG/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALGANCICLOVIR HCL 50 MG/ML, is $1.0058 per ML — about 24% below VALGANCICLOVIR HCL 50 MG/ML.
Who manufactures VALGANCICLOVIR HCL 50 MG/ML?
VALGANCICLOVIR HCL 50 MG/ML (NDC 00904741904) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.